Merck KGaA Plans $105 Million China Plant For Just Three Drugs
This article was originally published in PharmAsia News
Executive Summary
Merck KGaA said it plans to build a $104.8 million pharmaceutical plant in China's Jiangsu Province, with operations scheduled to begin in 2017.